NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Thursday that its second quarter revenues rose 64 percent, driven by strength in sales of its XT-8 eSensor molecular diagnostics system and its infectious disease menu.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.